Kinetic Textural Biomarker for Predicting Survival of Patients with Advanced Hepatocellular Carcinoma After Antiangiogenic Therapy by Use of Baseline First-Pass Perfusion CT

نویسندگان

  • Sang Ho Lee
  • Koichi Hayano
  • Dushyant V. Sahani
  • Andrew X. Zhu
  • Hiroyuki Yoshida
چکیده

Previous texture analysis studies of liver CT images have shown the potential to achieve hepatic malignancy or predict overall survival (OS). However, to date, most studies have mainly focused on assessing texture features of the noncontrast CT or portal-phase image in the dynamic contrast-enhanced CT sequence. The aim of this study was to quantify texture features of physiologically-based kinetic parametric images, and to develop prognostic kinetic textural biomarkers for 1-year survival (1YS) and OS in patients with advanced hepatocellular carcinoma (HCC) following antiangiogenic therapy in comparison among five different tracer kinetic models. Mean, standard deviation, coefficient of variation, skewness, and kurtosis of the pixel distribution histogram within HCC were derived from baseline first-pass perfusion CT parameters. Results suggest that texture analysis of kinetic parametric images can provide better chances of finding effective prognostic biomarkers for the prediction of survival than a mean value analysis alone.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparing PET metabolic parameters with clinicopathological factors in predicting onset of early recurrence in recently diagnosed hepatocellular carcinoma

Introduction: Early recurrence of hepatocellular carcinoma (HCC) is a major risk factor affecting survival even after hepatectomy. Many clinical, biochemical parameters and pathological grading like fibrosis 1 index have been used for risk stratifying HCC. However not many studies have combined all of them. It is therefore important to risk stratify HCC especially with newer PE...

متن کامل

Feasibility of 4D perfusion CT imaging for the assessment of liver treatment response following SBRT and sorafenib

OBJECTIVES To evaluate the feasibility of 4-dimensional perfusion computed tomography (CT) as an imaging biomarker for patients with hepatocellular carcinoma and metastatic liver disease. METHODS AND MATERIALS Patients underwent volumetric dynamic contrast-enhanced CT on a 320-slice scanner before and during stereotactic body radiation therapy and sorafenib, and at 1 and 3 months after treatm...

متن کامل

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy

BACKGROUND To investigate the hypothesis that MRI derived diffusion-weighted imaging (DWI) and perfusion (MRP) parameters are sensitive image biomarkers for monitoring early antiangiogenic effects and predicting progression free survival (PFS) in advanced hepatocellular carcinoma (HCC). METHODS In this phase II clinical trial, 23 of 34 patients were included in the imaging and circulating bio...

متن کامل

Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?

Antiangiogenic therapy, especially treatment with sorafenib, is the primary treatment for patients with advanced hepatocellular carcinoma (HCC). However, the efficacy of such therapy is modest, with low objective response rates and limited prolongation of survival times. Several researchers have investigated predictive biomarkers to help identify patients who can benefit most from antiangiogeni...

متن کامل

Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy.

PURPOSE Patients with liver cirrhosis or hepatocellular carcinoma (HCC) have decreased serum insulin-like growth factor (IGF)-1 levels. We evaluated whether IGF-1 levels were associated with the outcomes of patients with advanced HCC treated with systemic antiangiogenic therapy. EXPERIMENTAL DESIGN The study was based on patients with advanced HCC who were enrolled in two clinical trials eval...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014